COVID-associated arthritis after severe and non-severe COVID-19: A systematic review.
COVID-19 severity
COVID-associated arthritis
inflammatory arthritis
reactive arthritis
Journal
Immunity, inflammation and disease
ISSN: 2050-4527
Titre abrégé: Immun Inflamm Dis
Pays: England
ID NLM: 101635460
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
03
09
2023
received:
15
05
2023
accepted:
22
09
2023
medline:
1
11
2023
pubmed:
31
10
2023
entrez:
31
10
2023
Statut:
ppublish
Résumé
Since the coronavirus outbreak became a global health emergency in 2020, various immune-based effects, such as inflammatory arthritis (IA), have been recorded. This study aimed to determine the role of COVID-19 severity on post-COVID arthritis. We systematically reviewed 95 patients who developed arthritis after severe and non-severe COVID-19 infection by searching the databases, including PubMed, SCOPUS, and EMBASE. We used the term "COVID-associated arthritis" because there was no definite diagnostic method for classifying arthritides after COVID-19 infection, and the diagnosed arthritis types were based on the authors' viewpoints. After evaluating the data between the two severe and non-severe COVID-19-infected groups of patients, the results showed that the COVID-19 severity may affect the pattern of joint involvement in IA. In both groups, combination therapy, including oral nonsteroidal anti-inflammatory drugs with different types of corticosteroids, was the most common treatment. In addition, the mean age and comorbidities rate was higher in the severe COVID-19 group. Even though the patients in the severe COVID-19 group developed more serious COVID-19 symptoms, they experienced milder arthritis with better outcomes and more delayed onsets that required less aggressive therapy. We conclude that there may be an inverse relationship between COVID-19 severity and arthritis severity, possibly due to weaker immunity conditions following immunosuppressant treatments in patients with severe COVID-19.
Identifiants
pubmed: 37904701
doi: 10.1002/iid3.1035
pmc: PMC10566449
doi:
Substances chimiques
Immunosuppressive Agents
0
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1035Informations de copyright
© 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Références
Clin Rheumatol. 2021 Aug;40(8):3357-3362
pubmed: 33587197
Cureus. 2021 Sep 20;13(9):e18139
pubmed: 34692347
BMC Rheumatol. 2020 Oct 28;4:65
pubmed: 33123675
Ann Rheum Dis. 2021 Aug;80(8):1096-1098
pubmed: 33648960
Reumatol Clin. 2023 Feb;19(2):67-73
pubmed: 35578636
Arthritis Care Res (Hoboken). 2011 Nov;63(11):1565-70
pubmed: 21954118
Ann Rheum Dis. 2021 Jun;80(6):e91
pubmed: 32632032
Acta Reumatol Port. 2020 Oct-Dec;45(4):278-280
pubmed: 33420769
Clin Case Rep. 2022 Feb 07;10(2):e05430
pubmed: 35154733
North Clin Istanb. 2021 Aug 25;8(4):423-424
pubmed: 34585082
RMD Open. 2022 Sep;8(2):
pubmed: 36100294
J Clin Rheumatol. 2020 Sep;26(6):233
pubmed: 32694352
Ann Rheum Dis. 2023 Apr;82(4):e86
pubmed: 32753423
Indian J Pediatr. 2022 Jan;89(1):103
pubmed: 34687437
Clin Exp Rheumatol. 2023 Mar;41(3):656-666
pubmed: 35916289
Pediatr Rheumatol Online J. 2021 Jun 12;19(1):89
pubmed: 34118941
Lancet Rheumatol. 2020 Sep;2(9):e518-e519
pubmed: 32838313
Ann Rheum Dis. 2021 Apr;80(4):e58
pubmed: 32471899
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Cureus. 2020 Aug 12;12(8):e9698
pubmed: 32923288
Clin Exp Rheumatol. 2021 Jan-Feb;39 Suppl 128(1):25-26
pubmed: 33506755
RMD Open. 2022 Sep;8(2):
pubmed: 36096524
Lancet Rheumatol. 2020 Nov;2(11):e655-e657
pubmed: 33043303
Joint Bone Spine. 2020 Dec;87(6):660
pubmed: 32622040
Infection. 2023 Feb;51(1):37-45
pubmed: 35655110
Reumatol Clin (Engl Ed). 2022 Oct;18(8):490-492
pubmed: 35562296
Clin Rev Allergy Immunol. 2012 Feb;42(1):102-11
pubmed: 22095454
RMD Open. 2020 Aug;6(2):
pubmed: 32763956
J Infect Chemother. 2022 Apr;28(4):587-590
pubmed: 35016827
Indian J Hematol Blood Transfus. 2023 Jan;39(1):154-155
pubmed: 36699433
Medicine (Baltimore). 2021 Jun 11;100(23):e26089
pubmed: 34114992
Trop Dis Travel Med Vaccines. 2021 Jun 15;7(1):18
pubmed: 34130744
Viruses. 2021 Aug 06;13(8):
pubmed: 34452422
Rheumatol Adv Pract. 2021 Feb 04;5(1):rkab001
pubmed: 33615130
Cureus. 2022 Apr 13;14(4):e24096
pubmed: 35573487
Rheumatol Int. 2021 Nov;41(11):2031-2039
pubmed: 34550429
Cureus. 2021 Oct 9;13(10):e18620
pubmed: 34765373
Immunology. 2020 Jul;160(3):261-268
pubmed: 32460357
Reumatismo. 2021 Apr 19;73(1):59-63
pubmed: 33874649
Rheumatology (Oxford). 2021 Jul 1;60(7):e232-e233
pubmed: 33471106
Cureus. 2020 Nov 28;12(11):e11761
pubmed: 33409010
Clin Case Rep. 2020 Nov 16;9(1):304-308
pubmed: 33362924
Clin Rheumatol. 2022 Jun;41(6):1641-1652
pubmed: 35247132
Immun Inflamm Dis. 2021 Sep;9(3):628-631
pubmed: 33979033
BMJ Glob Health. 2021 Dec;6(12):
pubmed: 34916273
Adv Respir Med. 2021;89(2):135-144
pubmed: 33966261
Ann Rheum Dis. 2021 Jun;80(6):e101
pubmed: 32591356
J Med Virol. 2021 Jan;93(1):192-193
pubmed: 32652541
BMJ Case Rep. 2021 Mar 2;14(3):
pubmed: 33653867